NORDIC BIOSCIENCE
LIVE

Serial Number

79378675

Owner

Nordic Bioscience A/S

Attorney

Andrew M. Smith

Filing Date

Jul 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NORDIC BIOSCIENCE Trademark

Serial Number: 79378675 • Registration: 8072442

NORDIC BIOSCIENCE is a trademark filed by Nordic Bioscience A/S on July 19, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Nordic Bioscience A/S (10 trademarks)

Herlev Hovedgade 205-207

Entity Type: 99

Trademark Details

Filing Date

July 19, 2023

Registration Date

December 23, 2025

Published for Opposition

November 4, 2025

Goods & Services

diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, disease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detection, disease detection, disease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use

custom design and development of blood-based biomarker assays to identify, quantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medical, pharmaceutical, and scientific purposes; custom design and development of biochemical, pharmaceutical, and medical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical and scientific research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysis, namely, analysis of pharmacodynamic data; biological research and analysis, namely, analysis of data relating to biomarkers; development services in the field of diagnostic preparations, equipment and tests; medical and scientific research, namely, conducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; advice, information and assistance relating to the foregoing

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 23, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 7, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 7, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 7, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 7, 2025 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 1, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 12, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Feb 12, 2025 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 5, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 5, 2024 TROA
REFUSAL PROCESSED BY IB
Jun 3, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 10, 2024 RFCS
REFUSAL PROCESSED BY MPU
May 10, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 4, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 3, 2024 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
May 3, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 3, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 2, 2024 CNRT
ASSIGNED TO EXAMINER
Mar 25, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 19, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 14, 2023 REPR